38371-84-5

Usage

Uses

Used in Pharmaceutical Industry:
LDN-0064229 is used as a PDE2A inhibitor for its potential therapeutic applications in treating central nervous system disorders such as schizophrenia, bipolar disorder, and neuroinflammatory conditions. Its ability to modulate neurotransmission and improve cognitive function makes it a promising candidate for novel treatment approaches in these areas.
Used in Research and Development:
LDN-0064229 is used as a research tool in preclinical studies to investigate its effects on memory and cognitive function in animal models. This helps in understanding the compound's therapeutic potential and safety profile, paving the way for further development and clinical trials in humans.

Upstream product

• 65599-35-1 1-(2-hydroxyphenyl)-3-(furan-2-yl)propane-1,3-dione 
• 153685-74-6 2-Furan-2-yl-5-oxa-3,3a-diaza-cyclopenta[a]naphthalen-4-one 
• 153685-72-4 2-Furan-2-yl-1,9b-dihydro-5-oxa-3,3a-diaza-cyclopenta[a]naphthalen-4-one 
• 118-93-4 o-hydroxyacetophenone 
• 72738-17-1 2-acetylphenyl furan-2-carboxylate 
• 88-14-2 2-furanoic acid 
• 75201-03-5 5-(2-furyl)-4,5-dihydro-3-(2-hydroxyphenyl)pyrazole 
• 2875-23-2 (E)-3-(2-furanyl)-1-(2'-hydroxyphenyl)-2-propen-1-one 

Relevant academic research and scientific papers

Synthesis and molluscicidal activity of new derivatives of 1-(hydroxy/substituted phenyl)-3-arylpropenones

Several 1-(hydroxy/substituted phenyl)propenones were tested as molluscicidal agents among which the 1-(2-hydroxy/substituted phenyl)-3-(2-furyl)propenones 1a-c show the most promising results. In an attempt to improve their activity, new dihydropyrazolo[

Synthesis and Reactions of 1-(2'-Furyl)-3-(substituted-2''-hydroxyphenyl)propanediones

The title compounds (III) have been synthesised by the base-catalysed Baker-Venkataraman transformation of furoyl esters (II) of substituted 2-hydroxyacetophenones.These propanediones (III) on acid cyclization, bromination, treatment with SO2Cl2, and cond

Synthesis and Antimicrobial Activity of Hydroxyarylpyrazoles

Hydroxyarylpyrazolines (III) and Pyrazoles (IV) have been synthesized.Compounds IVa and IVd exhibit marked antifungal activity against A. niger, C. albicans, C. neoformans, T. mentagraphytes and M. canis whereas compound IVc shows activity against the last three fungi.None of the compounds shows any noteworthy antibacterial activity against Staphy. aureus, Staphi. typhi and Esch. coli even at 100 μg/ml.